- Daiichi Sankyo, Inc. (Bernards, NJ)
- …as other research areas centered around rare diseases and immune disorders. Summary The Associate Director , Global Oncology Medical Affairs, Medical ... to improve standards of care and address diversified, unmet medical needs of people globally by leveraging our world-class...diseases, under the Group's 2025 Vision to become a " Global Pharma Innovator with Competitive Advantage in Oncology… more
- Daiichi Sankyo, Inc. (Bernards, NJ)
- …areas centered around rare diseases and immune disorders. SummaryThe Associate Director Global Medical Affairs Oncology (GMA), under the direction of the ... Senior Director / Director , GMA Oncology ( Global Medical Affairs team lead for compound), is responsible for assisting with defining compound/program … more
- Daiichi Sankyo, Inc. (Bernards, NJ)
- …well as other research areas centered around rare diseases and immune disorders. SummaryThe Director US Medical Affairs (USMA) Oncology , under the direction ... diseases, under the Group's 2025 Vision to become a " Global Pharma Innovator with Competitive Advantage in Oncology...of the Senior Director , USMA Oncology (US Medical Affairs team lead for… more
- Daiichi Sankyo, Inc. (Bernards, NJ)
- …compound under the supervision and leadership of the Executive Director of Medical Research and Strategy, US Oncology Medical Affairs (USOMA). Develops ... diseases, under the Group's 2025 Vision to become a " Global Pharma Innovator with Competitive Advantage in Oncology...Launch Readiness activities and life cycle management from a medical perspective- Participates in Global Medical… more
- Merck & Co. (Upper Gwynedd, PA)
- Job DescriptionOur company is a global health care leader with a diversified portfolio of prescription medicines, vaccines and animal health products. The difference ... and an inspiring mission to achieve new milestones in global healthcare. Our Company is on a quest for...changes the way we approach serious diseases. --The Senior Director will report to an Associate Vice President in… more
- Daiichi Sankyo, Inc. (Bernards, NJ)
- …medicines for cardiovascular diseases, under the Group's 2025 Vision to become a " Global Pharma Innovator with Competitive Advantage in Oncology ," Daiichi Sankyo ... cross-functional partners and if applicable, Alliance counterparts.Responsibilities- Partners with US Medical Affairs Oncology and stakeholders in Daiichi Sankyo… more
- Daiichi Sankyo, Inc. (Chesapeake, VA)
- …medicines for cardiovascular diseases, under the Group's 2025 Vision to become a " Global Pharma Innovator with Competitive Advantage in Oncology ," Daiichi Sankyo ... to improve standards of care and address diversified, unmet medical needs of people globally by leveraging our world-class...is primarily focused on providing novel therapies in oncology , as well as other research areas centered around… more
- Daiichi Sankyo, Inc. (San Francisco, CA)
- …US-managed markets preferredPrevious experience in Oncology , clinical research and medical education preferred Principal MSL/Associate Director MSL5 or More ... medicines for cardiovascular diseases, under the Group's 2025 Vision to become a " Global Pharma Innovator with Competitive Advantage in Oncology ," Daiichi Sankyo… more
- Daiichi Sankyo, Inc. (Bernards, NJ)
- …medicines for cardiovascular diseases, under the Group's 2025 Vision to become a " Global Pharma Innovator with Competitive Advantage in Oncology ," Daiichi Sankyo ... to improve standards of care and address diversified, unmet medical needs of people globally by leveraging our world-class...is primarily focused on providing novel therapies in oncology , as well as other research areas centered around… more
- Daiichi Sankyo, Inc. (Bernards, NJ)
- …medicines for cardiovascular diseases, under the Group's 2025 Vision to become a " Global Pharma Innovator with Competitive Advantage in Oncology ," Daiichi Sankyo ... to improve standards of care and address diversified, unmet medical needs of people globally by leveraging our world-class...is primarily focused on providing novel therapies in oncology , as well as other research areas centered around… more
- Daiichi Sankyo, Inc. (Bernards, NJ)
- …medicines for cardiovascular diseases, under the Group's 2025 Vision to become a " Global Pharma Innovator with Competitive Advantage in Oncology ," Daiichi Sankyo ... to improve standards of care and address diversified, unmet medical needs of people globally by leveraging our world-class...centered around rare diseases and immune disorders. Job Summary: Director , Global QA Strategy &Operations ( Global… more
- Daiichi Sankyo, Inc. (Bernards, NJ)
- …medicines for cardiovascular diseases, under the Group's 2025 Vision to become a " Global Pharma Innovator with Competitive Advantage in Oncology ," Daiichi Sankyo ... to improve standards of care and address diversified, unmet medical needs of people globally by leveraging our world-class...is primarily focused on providing novel therapies in oncology , as well as other research areas centered around… more
- Daiichi Sankyo, Inc. (Bernards, NJ)
- …initiatives for continuous quality improvement.Deputize for the Sr. Director , Medical Affairs QA as needed. Cross-functional and Global Team ... diseases, under the Group's 2025 Vision to become a " Global Pharma Innovator with Competitive Advantage in Oncology...and immune disorders. Job Summary: Reporting to the Sr. Director , Medical Affairs QA, the Director… more
- Eisai, Inc (Nutley, NJ)
- …and make a difference. If this is your profile, we want to hear from you. The Oncology US Medical Excellence and Training role will work closely with Global ... Medical Education and Training colleagues and with the Global & US MALT ( Medical Affairs Leadership...medical affairs/ excellence, or related and relevant function. Oncology disease management knowledge in the therapeutic areas of… more
- Daiichi Sankyo, Inc. (Bernards, NJ)
- …medicines for cardiovascular diseases, under the Group's 2025 Vision to become a " Global Pharma Innovator with Competitive Advantage in Oncology ," Daiichi Sankyo ... to improve standards of care and address diversified, unmet medical needs of people globally by leveraging our world-class...disorders. Under the Group's 2025 Vision to become a " Global Pharma Innovator with Competitive Advantage in Oncology… more
- Genmab (NJ)
- …and serious diseases. We strive to create, champion and maintain a global workplace where individuals' unique contributions are valued and drive innovative solutions ... love to have you join us!The RoleThe Regional Business Director will help recruit, hire, develop, and lead his/her...his/her sales team in solid tumor for Genmab's US Oncology sales organization. This person will be responsible for… more
- Daiichi Sankyo, Inc. (Bernards, NJ)
- …of 5 years of (in-house) medical affairs or related experience, global preferred required- Must have oncology experience, specifically in solid tumors ... diseases, under the Group's 2025 Vision to become a " Global Pharma Innovator with Competitive Advantage in Oncology...asset compounds under the supervision and leadership of the Global Medical Affairs (GMA) Franchise Head. Develops… more
- Eisai, Inc (Nutley, NJ)
- …input to the health economics and outcomes research strategies, and timelines with medical affairs, marketing, managed markets and global value and access teams. ... At Eisai, satisfying unmet medical needs and increasing the benefits healthcare provides...pharmaceutical company that is breaking through in neurology and oncology , with a strong emphasis on research and development.… more
- Daiichi Sankyo, Inc. (Bernards, NJ)
- …medicines for cardiovascular diseases, under the Group's 2025 Vision to become a " Global Pharma Innovator with Competitive Advantage in Oncology ," Daiichi Sankyo ... to improve standards of care and address diversified, unmet medical needs of people globally by leveraging our world-class...is primarily focused on providing novel therapies in oncology , as well as other research areas centered around… more
- Daiichi Sankyo, Inc. (Bernards, NJ)
- …medicines for cardiovascular diseases, under the Group's 2025 Vision to become a " Global Pharma Innovator with Competitive Advantage in Oncology ," Daiichi Sankyo ... to improve standards of care and address diversified, unmet medical needs of people globally by leveraging our world-class...is primarily focused on providing novel therapies in oncology , as well as other research areas centered around… more
